PCK 11.1% 4.0¢ painchek ltd

PainChek General Discussion, page-20285

  1. 162 Posts.
    lightbulb Created with Sketch. 125
    Hi Rorbag - cap raise assessment was back of the envelope... Costs approx $8M pa. AAR currently $1.8M and predicted to go to a maximum of $4.2M by "early 2023". So approx a $4M shortfall with $6.9M in the bank. Need to double the assumed AAR revenue of $4.2M to cover costs to be sustainable. So they have 5 to 6 quarters to do this to avoid another cap raise. Not an insignificant task - but lots of irons in the fire

    Risks are:
    • Cost base increase due to international expansion, infant app launch, FDA approval?
    • Slower rate of implementation of current licences
    • Poor conversion of the $2M AAR govt funded beds to commercial contracts. Hard to believe there is still 12,870 beds ($0.5M) that were govt funded but not yet implemented

    I'm slightly more optimistic than Fattchoi & Screenlover and reckon PCK will be revenue neutral in 2024 rather than 2025 - but have been wrong before!!! Also believe/hopeful that there should be healthy SP growth over this time

    Saw Portugal but not Brazil or Canada - but use the free version of APPlyzer
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.004(11.1%)
Mkt cap ! $65.43M
Open High Low Value Volume
3.6¢ 4.0¢ 3.5¢ $58.14K 1.592M

Buyers (Bids)

No. Vol. Price($)
3 606713 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 1458683 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.